Clinical Trial Update: Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy and safety of a 14-day concomitant therapy for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN